Recent News

• 03.27.2026 - Liquid Biopsy: Entering a New Phase in Cancer Diagnostics
• 02.26.2026 - What Would It Take to Bring NGS to the Point of Need
• 02.24.2026 - Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio
• 02.18.2026 - Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit.

Recent Filings

• 03.27.2026 - 3 Initial statement of beneficial ownership of securities
• 03.25.2026 - 3 Initial statement of beneficial ownership of securities
• 03.25.2026 - 3 Initial statement of beneficial ownership of securities
• 03.20.2026 - EX-99.1 EX-99.1
• 03.20.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.18.2026 - EX-99.1 EX-99.1
• 03.18.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.16.2026 - EX-99.1 EX-99.1
• 03.16.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.13.2026 - S-8 Securities to be offered to employees in employee benefit plans